SEC Tracker
Get the app
CERS · XBRL financial data

Cerus financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (CERS's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customersyear only———year only43525385*545758
Selling, general and administrative17*20191819*20211921*202322
Total operating expenses32*34343235*37403437*343736
Operating income (loss)1*(8)(4)(1)(1)*(6)(3)1(1)*(0)(2)0
Interest expense2*2222*2222*221
Other income (expense)1*0011*1111*110
Income tax expense (benefit)0*0(0)00*0000*000
Net income (loss)(1)*(10)(6)(3)(3)*(8)(6)(0)(2)*(2)(3)(1)
Earnings per share, basic USD per share(0.01)*(0.05)(0.03)(0.02)(0.01)*(0.04)(0.03)0.00(0.01)*(0.01)(0.01)0.00
Earnings per share, diluted USD per share(0.01)*(0.05)(0.03)(0.02)(0.01)*(0.04)(0.03)0.00(0.01)*(0.01)(0.01)0.00
Weighted average shares, basic millions of shares181*182185185186*187191192192*194201202
Weighted average shares, diluted millions of shares181*182185185186*187191192192*194201202

Balance sheet

CSV

Fiscal quarters (CERS's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents122112222019161620281816
Marketable securities545259546061626363533841
Accounts receivable362324243026313030293131
Inventory404036373848555356616665
Prepaid and other current assets344446565444
Total current assets144138135141152162169167174175157157
Property and equipment, net988777779999
Right-of-use asset1110109899810999
Goodwill111111111111
Total assets198189185190201207213215222223205205
Accounts payable241717162228312528323426
Accrued liabilities191615161917212225181721
Total current liabilities68575454647084881011078680
Lease liability, non-current141313121212111110998
Total liabilities144139135135144151157153157155134128
Accumulated deficit(1,045)(1,054)(1,060)(1,063)(1,066)(1,073)(1,079)(1,079)(1,081)(1,083)(1,086)(1,086)
Total stockholders' equity534950535655556164687076
Total liabilities and equity198189185190201207213215222223205205
Common shares outstanding (cover page) millions of shares181185185186186191192192192200202202

Cash flows

CSV

Fiscal quarters (CERS's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)(1)*(10)(6)(3)(3)*(8)(6)(0)(2)*(2)(3)(1)
Stock-based compensation5*66*6*6*76*6*5*55*6*
Depreciation and amortization1*10*0*0*00*0*0*00*0*
Net cash from operating activities(15)*20*4*5*(1)(2)*2*6*(3)(3)*3*
Purchases of property and equipment(0)*10*1*1*00*2*1*01*1*
Net cash from investing activities8*1(7)*5*(7)*(1)(1)*(3)*(1)*1013*(3)*
Proceeds from issuing common stock(0)*0(0)*(0)*(0)*(0)(0)*0*0*0(0)*0*
Proceeds from long-term debt———0*————————
Repayments of long-term debt———————————0*
Net cash from financing activities1*6(1)*0*1*1(0)*0*(1)*1(20)*(1)*
Net change in cash(6)*9(8)*9*(2)*(1)(3)*(0)*4*8(10)*(2)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingRunwayQuarter
Cerus16583*202.0M— 10-QSep 30, 2026
SANUWAVE Health9.49.70.4*8.6M— 10-QJun 30, 2026
Electromed2019*3*8.4M— 10-KJun 30, 2026
Tactile Systems Technology759212*22.4M— 10-QSep 30, 2026
Orasure Technologies16131(9.9)*69.0M16.2 quarters 10-QJun 30, 2026
Heartflow3464(8.6)*87.0M19.0 quarters 10-QJun 30, 2026
Bioventus3114221*not reported— 10-QSep 26, 2026
Treace Medical Concepts1345(4.7)*65.0M9.7 quarters 10-QJun 30, 2026
SS Innovations International14not reported(4.2)*200.4M3.2 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.